Inhibition Of Alloreactivity By Modulation Of Antigen Presenting Cells
Funder
National Health and Medical Research Council
Funding Amount
$504,097.00
Summary
Bone marrow transplantation (BMT) is the most effect treatment for a number of conditions, especially leukemia. Graft versus host disease (GVHD) is a complication of BMT and results in the death of up to 50% of transplant recipients. GVHD occurs when the newly transplanted immune system recognizes the recipient as foreign and mounts and immune reponse against the patients tissues. These studies will focus on identifying and understanding the function of the immune cells which drive GVHD.
Regulation Of T Follicular Helper Cell Development And Effector Function In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$419,197.00
Summary
Immune cells mature into distinct populations with specialized functions. One subsets are T follicular helper (TFH) cells which are important for instructing B cells to produce antibodies following infection or vaccination. The means by which TFH cells are generated are unknown. We will determine mechanisms whereby TFH cells are produced and how they function. We hope to design approaches that will modulate the function of TFH cells in cases of immunodeficiencies, autoimmunity or vaccination.
Follicular T Helper Cells: Critical Regulators Of Humoral Immune Responses
Funder
National Health and Medical Research Council
Funding Amount
$272,591.00
Summary
B cells are important cells of the immune system that are responsible for producing antibodies in response to infection with pathogens, such as bacteria or viruses, or following vaccinations. In order for B cells to accomplish this task, they require help from a specialised popualtion of T cells, which are another type of immune cell - these are known as follicular T helper (TFH) cells. Under normal circumstances, T cells and B cells specifically interact with one another within lymphoid tissues ....B cells are important cells of the immune system that are responsible for producing antibodies in response to infection with pathogens, such as bacteria or viruses, or following vaccinations. In order for B cells to accomplish this task, they require help from a specialised popualtion of T cells, which are another type of immune cell - these are known as follicular T helper (TFH) cells. Under normal circumstances, T cells and B cells specifically interact with one another within lymphoid tissues such as tonsils, spleens and lymph nodes - here, they engage in a dialogue, the end result of which is the B cells being instructed to produce the appropriate type of antibodies by T cells. However, if tis process is not regulated, the T cells can deliver too little of too much help - this can result in several different types of diseases of the immune system, such as immunodeficiencies (ie insufficient production of antibodies, resulting in individuals becoming susceptible to infections) or autoimmunity (ie production of inappropriate types of antibodies that can recognise cells of the host, resulting in tissue damage and organ failure). The means by which TFH cells instruct B cells to produce antibodies is not completely understood. This project will seek to determine the mechanism whereby TFH cells carry out this important function by performing detailed examination of them follwoing their removal from tissues such as human tonsils and spleens. In doing so, we hope to design approaches that will allow the function of TFH cells to be improved in cases of immunodeficiencies, or suppressed in situations of autoimmune diseases.Read moreRead less
The Impact Of Obesity On Immunological Tolerance Of The Fetus
Funder
National Health and Medical Research Council
Funding Amount
$378,366.00
Summary
Obesity increases the risk of miscarriage during pregnancy. The reasons for this are not known, although it is thought that abnormal levels of hormones and metabolic parameters are a contributing factor. We hypothesise that the immune system plays a role. In this project we will determine if obesity upsets the fine-tuning of the immune system that is crucial for successful pregnancy. Understanding the reason behind adverse pregnancy outcome will allow appropriate management of maternal obesity.
The Molecular Determinants Of Immunological Tolerance
Funder
National Health and Medical Research Council
Funding Amount
$473,477.00
Summary
Autoimmune diseases, such as type I diabetes and multiple sclerosis, are debilitating disorders that impose a massive toll on wellbeing in Australia and worldwide. This fellowship will support research aimed at determining the genes and mechanisms that control autoimmunity. New technologies will be brought to bear to track immune cells throughout their development, maturity and malfunction in disease settings. We aim to uncover new therapeutic targets to prevent and reverse autoimmune disease.
This application seeks information on the factors controlling T cell survival, tolerance and responsiveness to foreign antigens and tumour antigens. Particular attention will be directed to determining how T cells are kept alive through contact with self ligands and cytokines while preserving self tolerance and how anti-tumour responses can improved without augmenting the function of T regulatory cells.
Cancer is one of the leading causes of death in the industrialized world. While therapies to treat cancer have continued to improve one area that, in theory at least, shows great promise in the treatment of tumours is manipulating the immune system to effectively recognize and destroy cancerous lesions. Experiments in human and animal systems have clearly shown that the immune system has the potential to respond to tumour cells and trials of tumour vaccines are underway. It has recently become a ....Cancer is one of the leading causes of death in the industrialized world. While therapies to treat cancer have continued to improve one area that, in theory at least, shows great promise in the treatment of tumours is manipulating the immune system to effectively recognize and destroy cancerous lesions. Experiments in human and animal systems have clearly shown that the immune system has the potential to respond to tumour cells and trials of tumour vaccines are underway. It has recently become apparent that the immune responses to tumours may be inhibited by classes of regulatory immune cells. Eliminating these cells results in a more vigorous and effective anti-tumour response. This project will seek to discover the mechanisms of action of theses regulatory immune cells in order to devise more effective anti-cancer vaccines and therapies.Read moreRead less